News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17775)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (271)
2 (256)
3 (204)
4 (247)
5 (146)
6 (8)
7 (6)
8 (213)
9 (225)
10 (220)
11 (227)
12 (147)
13 (21)
14 (9)
15 (248)
16 (263)
17 (190)
18 (210)
19 (103)
20 (3)
21 (7)
22 (262)
23 (241)
24 (210)
25 (179)
26 (144)
27 (3)
28 (6)
29 (213)
30 (253)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Policy
World’s first iLDC enabling ADC drug receives IND clearance by the US FDA
GeneQuantum Healthcare has recently received the US IND approval for its in-house developed next generation antibody drug conjugate asset, GQ1001.
June 11, 2020
·
4 min read
Business
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation
Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group announce a partnership to deepen the integration between Synthace’s Antha software and Tecan’s Te-Chrom™ automated chromatography system to unlock the full potential of miniaturized protein purification.
June 11, 2020
·
5 min read
Business
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board
Harbour BioMed announced the appointment of Dr. Jon Wigginton M.D., to the company’s scientific advisory board.
June 11, 2020
·
3 min read
MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence
MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has assigned an Ambulatory Payment Classification (APC) code 5722 for the MolecuLight i:X imaging procedure for point-of-care real-time fluorescence wound imaging for bacterial presence, location and load
June 11, 2020
·
3 min read
Deals
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market
BIOLASE, Inc. announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately $6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to purchase common stock in a concurrent private placement.
June 11, 2020
·
4 min read
Business
Praxis Precision Medicines Promotes Business Leader Stuart Chaffee to Chief Financial Officer
Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, announced the promotion of Stuart Chaffee, Ph.D., to chief financial officer, effective immediately.
June 11, 2020
·
2 min read
Business
Aerie Pharmaceuticals Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
Aerie Pharmaceuticals, Inc. announced that Peter J. McDonnell, M.D., has been appointed to the Company’s Board of Directors and will also be a member of both the Nominating and Corporate Governance and Compensation Committees of the Board.
June 11, 2020
·
8 min read
Deals
LivaNova Announces New Senior Secured Credit Facility
LivaNova PLC announced its entry into a five-year $450 million senior secured credit facility through its wholly owned U.S. subsidiary, LivaNova USA, Inc. with funds managed by affiliates of Ares Management Corporation, as administrative agent and collateral agent.
June 11, 2020
·
3 min read
Pharm Country
Antares Pharma to Present at the Raymond James Human Health Innovation Conference
Antares Pharma, Inc., announced that Robert F. Apple, President and Chief Executive Officer, will present at the Raymond James Human Health Innovation Conference on Thursday, June 18, 2020 at 9:40 a.m. Eastern Time.
June 11, 2020
·
4 min read
Business
Arvinas Appoints Linda Bain to its Board of Directors
Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that Linda Bain has joined its Board of Directors.
June 11, 2020
·
2 min read
Previous
8 of 23
Next